These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1505460)

  • 21. Phenotype-associated changes in the effects of 1,25-dihydroxyvitamin D3 on alkaline phosphatase and bone GLA-protein of rat osteoblastic cells.
    Spiess YH; Price PA; Deftos JL; Manolagas SC
    Endocrinology; 1986 Apr; 118(4):1340-6. PubMed ID: 3485045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Partial characterization of a parathyroid hormone-stimulated resorption factor(s) from osteoblast-like cells.
    Perry HM; Skogen W; Chappel J; Kahn AJ; Wilner G; Teitelbaum SL
    Endocrinology; 1989 Oct; 125(4):2075-82. PubMed ID: 2791978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dexamethasone stimulates osteoclast-like cell formation by directly acting on hemopoietic blast cells and enhances osteoclast-like cell formation stimulated by parathyroid hormone and prostaglandin E2.
    Kaji H; Sugimoto T; Kanatani M; Nishiyama K; Chihara K
    J Bone Miner Res; 1997 May; 12(5):734-41. PubMed ID: 9144339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
    Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
    J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of parathyroid hormone or 1,25-dihydroxyvitamin D3 on monocyte-osteoclast fusion.
    Teti A; Volleth G; Carano A; Zambonin Zallone A
    Calcif Tissue Int; 1988 May; 42(5):302-8. PubMed ID: 3135098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Osteoblastic regulation of osteoclast survival: effect of calcitriol].
    Mentaverri R; Lorget F; Wattel A; Maamer M; Kamel S; Brazier M
    C R Acad Sci III; 2000 Nov; 323(11):951-7. PubMed ID: 11144027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alendronate interacts with the inhibitory effect of 1,25(OH)2D3 on parathyroid hormone-related protein expression in human osteoblastic cells.
    Gómez-García L; Esbrit P; Carreño L; Sabando P; García-Flores M; Martinez ME
    J Bone Miner Res; 2003 Jan; 18(1):78-87. PubMed ID: 12510808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of osteoclast formation by parathyroid hormone depends on an action on stromal cells.
    Fuller K; Owens JM; Chambers TJ
    J Endocrinol; 1998 Sep; 158(3):341-50. PubMed ID: 9846163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.
    Hill PA; Reynolds JJ; Meikle MC
    Endocrinology; 1995 Jan; 136(1):124-31. PubMed ID: 7828521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteoclast resorption-stimulating activity is associated with the osteoblast cell surface and/or the extracellular matrix.
    Fuller K; Gallagher AC; Chambers TJ
    Biochem Biophys Res Commun; 1991 Nov; 181(1):67-73. PubMed ID: 1958220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation by retinoic acid of 1,25-dihydroxyvitamin D3 effects on alkaline phosphatase activity and parathyroid hormone responsiveness in an osteoblast-like osteosarcoma cell line.
    Grigoriadis AE; Petkovich PM; Rosenthal EE; Heersche JN
    Endocrinology; 1986 Aug; 119(2):932-9. PubMed ID: 3015560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of calcitonin receptors by 1 alpha, 25-dihydroxyvitamin D3 in osteoclast-like multinucleated cells formed from mouse bone marrow cells.
    Takahashi N; Akatsu T; Sasaki T; Nicholson GC; Moseley JM; Martin TJ; Suda T
    Endocrinology; 1988 Sep; 123(3):1504-10. PubMed ID: 2841098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cellular actions of interleukin-11 on bone resorption in vitro.
    Hill PA; Tumber A; Papaioannou S; Meikle MC
    Endocrinology; 1998 Apr; 139(4):1564-72. PubMed ID: 9528935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effect of ipriflavone on osteoclast-mediated bone resorption and new osteoclast formation in long-term cultures of mouse unfractionated bone cells.
    Notoya K; Yoshida K; Taketomi S; Yamazaki I; Kumegawa M
    Calcif Tissue Int; 1993 Sep; 53(3):206-9. PubMed ID: 8242474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are osteoblastic cells required for the control of osteoclast activity by parathyroid hormone?
    Jilka RL
    Bone Miner; 1986 Sep; 1(4):261-6. PubMed ID: 2849485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrophage colony-stimulating factor release and receptor expression in bone cells.
    Weir EC; Horowitz MC; Baron R; Centrella M; Kacinski BM; Insogna KL
    J Bone Miner Res; 1993 Dec; 8(12):1507-18. PubMed ID: 8304053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophage colony-stimulating factor restores bone resorption in op/op bone in vitro in conjunction with parathyroid hormone or 1,25-dihydroxyvitamin D3.
    Morohashi T; Corboz VA; Fleisch H; Cecchini MG; Felix R
    J Bone Miner Res; 1994 Mar; 9(3):401-7. PubMed ID: 8191935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of bone resorption in osteosclerotic (oc/oc) mice is due to a defect in osteoclast progenitors rather than the local microenvironment provided by osteoblastic cells.
    Udagawa N; Sasaki T; Akatsu T; Takahashi N; Tanaka S; Tamura T; Tanaka H; Suda T
    Biochem Biophys Res Commun; 1992 Apr; 184(1):67-72. PubMed ID: 1567458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MLO-Y4 osteocyte-like cells support osteoclast formation and activation.
    Zhao S; Zhang YK; Harris S; Ahuja SS; Bonewald LF
    J Bone Miner Res; 2002 Nov; 17(11):2068-79. PubMed ID: 12412815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulatory effect of growth hormone on bone resorption and osteoclast differentiation.
    Nishiyama K; Sugimoto T; Kaji H; Kanatani M; Kobayashi T; Chihara K
    Endocrinology; 1996 Jan; 137(1):35-41. PubMed ID: 8536635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.